1 - 25 of 68 results for author:"Hertzog P." in Literature citations
Results Customize
› Repeat search in UniProtKB (31)
| Inflammasome-dependent IFN-gamma drives pathogenesis in Streptococcus pneumoniae meningitis. Mitchell A.J., Yau B., McQuillan J.A., Ball H.J., Too L.K., Abtin A., Hertzog P., Leib S.L., Jones C.A., Gerega S.K. et al. J. Immunol. 189:4970-4980(2012) · Mapped (28) |
| MyD88 drives the IFN-beta response to Lactobacillus acidophilus in dendritic cells through a mechanism involving IRF1, IRF3, and IRF7. Weiss G., Maaetoft-Udsen K., Stifter S.A., Hertzog P., Goriely S., Thomsen A.R., Paludan S.R., Frokiaer H. J. Immunol. 189:2860-2868(2012) · Mapped (53) |
| West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response. Schuessler A., Funk A., Lazear H.M., Cooper D.A., Torres S., Daffis S., Jha B.K., Kumagai Y., Takeuchi O., Hertzog P. et al. J. Virol. 86:5708-5718(2012) · Mapped (18) |
| The Ets transcription factor ELF5 functions as a tumor suppressor in the kidney. Lapinskas E.J., Svobodova S., Davis I.D., Cebon J., Hertzog P.J., Pritchard M.A. Twin Res Hum Genet 14:316-322(2011) · Mapped (3) |
| Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2. Piganis R.A., De Weerd N.A., Gould J.A., Schindler C.W., Mansell A., Nicholson S.E., Hertzog P.J. J. Biol. Chem. 286:33811-33818(2011) · Mapped (27) |
| Type I interferons suppress CD4⁺ T-cell-dependent parasite control during blood-stage Plasmodium infection. Haque A., Best S.E., Ammerdorffer A., Desbarrieres L., de Oca M.M., Amante F.H., de Labastida Rivera F., Hertzog P., Boyle G.M., Hill G.R. et al. Eur. J. Immunol. 41:2688-2698(2011) · Mapped (5) |
| Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Gantier M.P., McCoy C.E., Rusinova I., Saulep D., Wang D., Xu D., Irving A.T., Behlke M.A., Hertzog P.J., Mackay F. et al. Nucleic Acids Res. 39:5692-5703(2011) · Mapped (7) |
| HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production. Harman A.N., Lai J., Turville S., Samarajiwa S., Gray L., Marsden V., Mercier S.K., Mercier S., Jones K., Nasr N. et al. Blood 118:298-308(2011) · Mapped (6) |
| Macrophage activation and differentiation signals regulate schlafen-4 gene expression: evidence for Schlafen-4 as a modulator of myelopoiesis. van Zuylen W.J., Garceau V., Idris A., Schroder K., Irvine K.M., Lattin J.E., Ovchinnikov D.A., Perkins A.C., Cook A.D., Hamilton J.A. et al. PLoS ONE 6:e15723-e15723(2011) · Mapped (7) |
| IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3. Greenhill C.J., Rose-John S., Lissilaa R., Ferlin W., Ernst M., Hertzog P.J., Mansell A., Jenkins B.J. J. Immunol. 186:1199-1208(2011) · Mapped (40) |
| Transcript profiling of Elf5+/- mammary glands during pregnancy identifies novel targets of Elf5. Rogers R.L., Van Seuningen I., Gould J., Hertzog P.J., Naylor M.J., Pritchard M.A. PLoS ONE 5:e13150-e13150(2010) · Mapped (4) |
| Naive and activated T cells display differential responsiveness to TL1A that affects Th17 generation, maintenance, and proliferation. Jones G.W., Stumhofer J.S., Foster T., Twohig J.P., Hertzog P., Topley N., Williams A.S., Hunter C.A., Jenkins B.J., Wang E.C. et al. FASEB J. 25:409-419(2011) · Mapped (5) |
| Functional crosstalk between type I and II interferon through the regulated expression of STAT1. Gough D.J., Messina N.L., Hii L., Gould J.A., Sabapathy K., Robertson A.P., Trapani J.A., Levy D.E., Hertzog P.J., Clarke C.J. et al. PLoS Biol. 8:e1000361-e1000361(2010) · Mapped (20) |
| Cutting edge: pulmonary Legionella pneumophila is controlled by plasmacytoid dendritic cells but not type I IFN. Ang D.K., Oates C.V., Schuelein R., Kelly M., Sansom F.M., Bourges D., Boon L., Hertzog P.J., Hartland E.L., van Driel I.R. J. Immunol. 184:5429-5433(2010) · Mapped (6) |
| TRIL, a functional component of the TLR4 signaling complex, highly expressed in brain. Carpenter S., Carlson T., Dellacasagrande J., Garcia A., Gibbons S., Hertzog P., Lyons A., Lin L.L., Lynch M., Monie T. et al. J. Immunol. 183:3989-3995(2009) · UniProtKB (3) |
| Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. Thibault D.L., Graham K.L., Lee L.Y., Balboni I., Hertzog P.J., Utz P.J. Arthritis Res. Ther. 11:R112-R112(2009) · Mapped (6) |
| MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses. Verstak B., Nagpal K., Bottomley S.P., Golenbock D.T., Hertzog P.J., Mansell A. J. Biol. Chem. 284:24192-24203(2009) · Mapped (11) |
| GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on type I interferon signaling. Fleetwood A.J., Dinh H., Cook A.D., Hertzog P.J., Hamilton J.A. J. Leukoc. Biol. 86:411-421(2009) · Mapped (5) |
| Absence of glutathione peroxidase-1 exacerbates cerebral ischemia-reperfusion injury by reducing post-ischemic microvascular perfusion. Wong C.H., Bozinovski S., Hertzog P.J., Hickey M.J., Crack P.J. J. Neurochem. 107:241-252(2008) · Mapped (2) |
| GM-CSF-induced autoimmune gastritis in interferon alpha receptor deficient mice. Field J., Alderuccio F., Hertzog P., Toh B.H. J. Autoimmun. 31:274-280(2008) · Mapped (6) |
| Regulation of epithelium-specific Ets-like factors ESE-1 and ESE-3 in airway epithelial cells: potential roles in airway inflammation. Wu J., Duan R., Cao H., Field D., Newnham C.M., Koehler D.R., Zamel N., Pritchard M.A., Hertzog P., Post M. et al. Cell Res. 18:649-663(2008) · Mapped (4) |
| STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. Ernst M., Najdovska M., Grail D., Lundgren-May T., Buchert M., Tye H., Matthews V.B., Armes J., Bhathal P.S., Hughes N.R. et al. J. Clin. Invest. 118:1727-1738(2008) · Mapped (32) |
| A conserved IFN-alpha receptor tyrosine motif directs the biological response to type I IFNs. Zhao W., Lee C., Piganis R., Plumlee C., de Weerd N., Hertzog P.J., Schindler C. J. Immunol. 180:5483-5489(2008) · Mapped (13) |
| Type I IFN contributes to NK cell homeostasis, activation, and antitumor function. Swann J.B., Hayakawa Y., Zerafa N., Sheehan K.C., Scott B., Schreiber R.D., Hertzog P., Smyth M.J. J. Immunol. 178:7540-7549(2007) · Mapped (11) |
| TGF-betaRII rescues development of small intestinal epithelial cells in Elf3-deficient mice. Flentjar N., Chu P.Y., Ng A.Y., Johnstone C.N., Heath J.K., Ernst M., Hertzog P.J., Pritchard M.A. Gastroenterology 132:1410-1419(2007) · Mapped (8) |